Skip to content

Clinical trials

Phase 2 Carcinoma, Merkel Cell trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Merkel Cell Phase: Phase 2 Country / region: United States Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20121
20143
20152
20161
20173
20183
20193
20202
20215
20234
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting9
Recruiting7
Terminated5
Unknown status2
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)6
ImmunityBio, Inc.3
M.D. Anderson Cancer Center3
Memorial Sloan Kettering Cancer Center3
H. Lee Moffitt Cancer Center and Research Institute2
Abramson Cancer Center at Penn Medicine1
Burzynski Research Institute1
Dana-Farber Cancer Institute1
EMD Serono Research & Development Institute, Inc.1
Excel Diagnostics and Nuclear Oncology Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Merkel Cell35
Melanoma6
Carcinoma, Non-Small-Cell Lung4
Carcinoma, Renal Cell4
Skin Neoplasms4
Basal Cell Carcinoma3
Carcinoma, Neuroendocrine3
Carcinoma, Transitional Cell3
Colorectal Neoplasms3
Neoplasm Metastasis3

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.